# Olema Oncology, Inc.: Form 8-K, filed Jan 10, 2025

- Company: [Olema Oncology, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2025-01-10
- Accepted by EDGAR: Jan 10, 2025, 16:01 ET
- Period: 2025-01-10
- Accession: 0001193125-25-004427
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/d915597d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/d915597d8k.htm

Filed Jan 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-004427. Last ingested by Listed: Nov 13, 2026, 16:19 ET. No prices; not investment advice.